Navigation Links
Laser Deemed Best Treatment for Diabetic Retinopathy
Date:12/31/2009

Standard therapy still recommended over steroid injections, researchers say

THURSDAY, Dec. 31 (HealthDay News) -- Steroid injections into the eye slowed diabetes-related eye disease, though lasers remain the treatment of choice because of side effects related to the steroids, new research shows.

Researchers from the Johns Hopkins Wilmer Eye Institute gave 693 men and women who had diabetic retinopathy with macular edema either injections of a corticosteroid into their eyes as often as every four months or a laser photocoagulation, the standard treatment. The average age of the participants was 63.

Retinopathy is a long-term complication of diabetes that can lead to blindness. Macular edema, which can further interfere with vision, is a swelling of the central portion of the retina caused by fluid leakage.

Over time, retinopathy can advance to proliferative diabetic retinopathy, in which abnormal blood vessels grow on the optic nerve in the back of the eye, which communicates information from the retina to the brain, or elsewhere on the light-sensitive retina. The study authors found that steroid treatments reduced the risk of progression of diabetic retinopathy.

However, steroids did not prevent the progression of macular edema, according to the study.

And while steroids did help to improve the vision of participants, the results were no better than the laser treatments. Because the use of steroids in the eye can increase the risk of other eye diseases, including glaucoma and cataracts, lasers remain the treatment of choice for now, said lead study author Neil Bressler, a professor of ophthalmology and chief of the retina division of the eye institute.

"Steroid treatment worked, but because of safety issues, cannot be recommended routinely at this time," Bressler said in a news release from the institute. "It is a condition that can be treated safely and effectively with lasers."

The study findings are published in the December issue of Archives of Ophthalmology.

About 700,000 Americans have proliferative diabetic retinopathy, and 63,000 new cases develop each year, according to background information provided in the news release.

Corticosteroids may slow the progression of retinopathy by reducing the production of compounds that promote the growth of harmful new blood vessels, the researchers said.

More research is needed to determine if steroids can be used without increasing the risk of glaucoma or cataracts, the authors said.

More information

The U.S. National Eye Institute has more on diabetic retinopathy.



-- Jennifer Thomas



SOURCE: Johns Hopkins Wilmer Eye Institute, news release, Dec. 22, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Laser Spine Institute (LSI) Supports Jingle Bell Run
2. Entest BioMedical Enters into LOI with Advanced Light Devices to Develop Laser Platform for Stem Cell / Laser COPD Treatment
3. Entest Biomedical Enters into Discussions with Laser Manufacturer to Develop Proprietary Photoceutical Device for COPD Treatment
4. Dr. Arun Gulani Listed in Forbes Magazine as One of The Leading Laser Eye Surgeons of the United States
5. Laser therapy can aggravate skin cancer
6. Dishler Laser Institute Announces Dr. Jon Dishler Selected as a Leading Laser Eye Surgeon of the United States, as Seen in Forbes Magazine
7. Dishler Laser Institute Announces Dr. Jon Dishler Selected as a Leading Laser Eye Surgeon of the United States, as Seen in Forbes Magazine
8. Laser Therapy Seems to Relieve Neck Pain
9. Plastic Surgeons to Discuss Cleavage Rejuvenation, Do-It-Yourself Lasers and Other Hot Topics with the Media
10. First Temperature Monitoring Device for Laser Liposuction in St. Louis
11. Assara Laser Announces Strategic Alliance with Park Avenue Laser Vision
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2019)... , ... February 16, 2019 , ... ... launch of its rebranded product line celebrating the current trend for minimal packaging that ... of its legacy logo font and typewriter typography to tell its story. Presenting ...
(Date:2/16/2019)... ... 15, 2019 , ... SilcSkin – silicone anti-wrinkle pad pioneer and creator of ... Product for 2019 in the Neck and Decolleté category for the second time. The ... attendees of the International Congress of Esthetics and Spa. Developed by two-time Emmy award ...
(Date:2/16/2019)... ... February 15, 2019 , ... ... surgical centers (ASCs) throughout the U.S., celebrates the formation of its 200th ASC ... to open later this year. , “We continue to see the demand increase ...
(Date:2/14/2019)... ... 14, 2019 , ... At the 2019 Consumer Electronics Show ... Assistant (PCA 500), the only FDA-cleared, hospital quality, 12-lead electrocardiogram (ECG) for personal ... ECGs and identify arrhythmias, including atrial fibrillation or AFib. A 12-lead ECG can ...
(Date:2/14/2019)... (PRWEB) , ... February 14, 2019 , ... ... multi-year operating support which will directly impact Spaulding’s programs and services. , “The ... on our organization and in the lives of the children we serve for ...
Breaking Medicine News(10 mins):
(Date:2/14/2019)... , ... February 14, 2019 , ... ... Lewis and Clark College Emeritus Professor of Education Gregory A. Smith speaks with ... the emergence of Brand Ambassador programs, a new phenomenon in the marketing of ...
(Date:2/14/2019)... ... February 14, 2019 , ... ... minimally-invasive, innovative spinal technologies, today announced a corporate rebrand and name change ... commitment to delivering new, cutting-edge, surgical solutions that reestablish the standard of ...
(Date:2/13/2019)... ... February 14, 2019 , ... Entomol’s breakthrough safe ... the California EPA for release and sale within the state. California has the ... in Entomol‘s commercial development. This registration opens the door for wholesale/retail and military ...
Breaking Medicine Technology: